Health Care & Life Sciences » Biotechnology | ProMetic Life Sciences Inc.

ProMetic Life Sciences Inc. | Balance Sheet

Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
17,396.00
27,102.00
29,285.00
38,869.00
23,166.00
7,389
Total Accounts Receivable
14,172.00
12,751.00
8,438.00
8,790.00
10,955.00
Inventories
2,979.00
2,586.00
5,492.00
13,658.00
36,013.00
Other Current Assets
863.00
881.00
1,924.00
2,944.00
2,141.00
Total Current Assets
35,410.00
43,320.00
45,139.00
64,261.00
72,275.00
Net Property, Plant & Equipment
9,706.00
13,784.00
19,041.00
41,193.00
45,254.00
Total Investments and Advances
168.00
176.00
1,413.00
1,402.00
1,454.00
Long-Term Note Receivable
-
-
1,031.00
1,821.00
1,943.00
Intangible Assets
4,588.00
146,163.00
148,339.00
155,487.00
156,647.00
Other Assets
-
-
-
1,020.00
5,374.00
Total Assets
49,872.00
203,443.00
215,288.00
265,294.00
283,873.00
ST Debt & Current Portion LT Debt
6,487.00
3,191.00
424.00
6,147.00
5,502.00
Accounts Payable
4,650.00
9,102.00
11,044.00
14,269.00
19,333.00
Income Tax Payable
134.00
-
-
-
-
Other Current Liabilities
13,522.00
25,717.00
2,348.00
11,642.00
11,185.00
Total Current Liabilities
24,793.00
38,010.00
13,816.00
32,058.00
36,020.00
Long-Term Debt
6,217.00
23,244.00
24,159.00
44,135.00
84,391.00
Provision for Risks & Charges
-
-
-
-
214.00
Deferred Taxes
-
37,198.00
31,158.00
25,195.00
14,404.00
Other Liabilities
224.00
560.00
503.00
4,453.00
4,487.00
Total Liabilities
31,234.00
99,012.00
69,961.00
105,951.00
140,442.00
Common Equity (Total)
20,332.00
69,966.00
113,353.00
132,367.00
121,984.00
Total Shareholders' Equity
20,332.00
69,966.00
113,353.00
132,367.00
121,984.00
Total Equity
18,638.00
104,431.00
145,327.00
159,343.00
143,431.00
Liabilities & Shareholders' Equity
49,872.00
203,443.00
215,288.00
265,294.00
283,873.00
Accumulated Minority Interest
1,694.00
34,465.00
31,974.00
26,976.00
21,447.00

About ProMetic Life Sciences

View Profile
Address
440 Armand-Frappier Boulevard
Laval Québec H7V 4B4
Canada
Employees -
Website http://www.prometic.com
Updated 07/04/2019
Prometic Life Sciences, Inc. engages in the development of therapeutic products focusing on unmet medical needs in the field of fibrosis, autoimmune disease or inflammation, and cancer. It operates through the following segments: Bioseparations, Plasma-derived Therapeutics, and Small Molecule Therapeutics. The Bioseparations segment is involved in large-scale purification of biologics and the elimination of pathogens.